Gene therapy shows promise for rare eye disease causing blindness

NCT ID NCT02652780

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a one-time gene therapy injection, GS010, in 37 adults with Leber Hereditary Optic Neuropathy (LHON), a genetic condition that causes rapid vision loss. Participants had vision loss for 6 to 12 months before treatment. The goal was to see if the therapy could improve eyesight compared to a sham injection. Results measured changes in visual acuity over 48 and 96 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPTIC, ATROPHY, HEREDITARY, LEBER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Eye Diseases, Hereditary eye disorder hereditary disease hereditary optic atrophy inborn mitochondrial metabolism disorder Leber hereditary optic neuropathy nervous system disorder neurodegenerative disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre National Hospitalier d'Ophtalmologie des Quinze-Vingt

    Paris, Paris, France

  • Department of Neurology, University of Munich, Friedrich-Baur-Institute

    Munich, 80336, Germany

  • Department of Ophthalmology, Emory University School of Medicine

    Atlanta, Georgia, 30322, United States

  • Doheny Eye Center, University of California, Los Angeles

    Los Angeles, California, United States

  • IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Ospedale Bellaria

    Bologna, Bologna, Italy

  • Moorfields Eye Hospital NHS Foundation Trust

    London, EC1V 2PD, United Kingdom

  • Neuro Ophthalmologic Associates, Wills Eye Hospital, Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States